NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



Researchers at Washington University publish new data on angiogenesis



February 17th, 2009

According to recent research published in the journal Investigative Radiology, "The use of antiangiogenic therapy in conjunction with traditional chemotherapy is becoming increasingly in cancer management, but the optimal benefit of these targeted pharmaceuticals has been limited to a subset of the population treated. improved imaging probes that permit sensitive detection and high-resolution characterization of turner angiogenesis Could improve patient risk-benefit stratification. The overarching objective of these experiments was to develop a dual modality alpha(nu)beta(3)-targeted nanoparticle molecular imaging agent that affords sensitive nuclear detection in conjunction with...


Source: Cancer Weekly (2009-02-17)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login